InspireMD Announces Updated Timing for Third Quarter 2026 Financial Results

InspireMD (NSPR) rescheduled its third-quarter 2026 financial results call and webcast to the afternoon of November 12, 2026.

Rhea-AI Impact

(High)

Rhea-AI Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

InspireMD (NSPR) rescheduled its third-quarter 2026 financial results call and webcast to the afternoon of November 12, 2026. The call will begin at 4:30 p.m. Eastern Time, after U.S. markets close, rather than 8:30 a.m. Eastern Time. The company said the revised timing will allow management to provide a fuller update on recent developments and business activities alongside its financial results.

Key Terms

carotid stent

1 terms

carotid stent medical

"developer of the CGuard® Prime carotid stent system"

A carotid stent is a small metal mesh tube placed inside a narrowed carotid artery in the neck to prop the vessel open and help restore normal blood flow to the brain, typically delivered through the blood vessels using a thin tube. For investors, it matters because regulatory approvals, clinical trial results, insurance coverage and surgical adoption drive device sales, pricing and legal risk—think of it like a scaffold that keeps a critical pipeline open, affecting demand and revenue for makers.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

11/11/2026 - 04:05 PM EST

MIAMI, Nov. 11, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard^® Prime carotid stent system for the prevention of stroke, today announced that it has rescheduled its third quarter 2026 financial results conference call and webcast to 4:30 p.m. Eastern Time, after the close of U.S. financial markets on Thursday, November 12, 2026, from its previously announced time of 8:30 a.m. Eastern Time.

The revised timing will allow management to provide investors with a more comprehensive update on the Company’s recent developments and business activities in conjunction with its third quarter financial results.

Parties interested in participating by phone should register using this online form. After registering for the webcast, dial-in details will be provided in an auto-generated e-mail containing a link to the conference phone number along with a personal pin. A live audio webcast and an archive of the recording will be available here and through the Investors page of InspireMD’s corporate website at https://investors.inspiremd.com. Interested participants are encouraged to register more than 15 minutes before the start of the call.

About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com.

Investor Contact:
Jeff Warren
LifeSci Advisors
jwarren@lifesciadvisors.com
investor-relations@inspiremd.com